Department of urology, Peking University Shougang Hospital, Peking University Health Science Center, Beijing, 100144, China.
Peking University Wu Jieping Urology Center, Peking University Shougang Hospital, Peking University Health Science Center, 9# Jinyuanzhuang Road, Shijingshan district, Beijing, 100144, China.
BMC Urol. 2019 Nov 4;19(1):107. doi: 10.1186/s12894-019-0535-8.
To report a new standardized cognitive fusion technique on transperineal targeted biopsy (TB) of prostate, and to evaluate its efficacy for cancer detection combined with systematic biopsy (SB) .
We present a retrospective review of consecutive patients undergoing multiparametric magnetic resonance (mpMRI) imaging of the prostate with subsequent transperineal prostate biopsy from January 2016 to December 2018. A free-hand 12-core SB was performed for each patient. PI-RADS 3-5 lesions were further targeted for biopsy with our TB technique. Firstly, a central point of suspicious lesion (B') was registered cognitively on a transverse section of transrectal ultrasound (TRUS). Then, biopsy gun punctured vertically through a fixed pioneer site (A) on skin of perineum, and deep into the TRUS section to get A'. Next, targeted site (B), the surface-projection of B', would be determined on skin of perineum by A and distance from B' to A'. Finally, puncture through B to reach B'. Pathological findings of SB and TB were analyzed.
A total of 126 patients underwent transperineal prostate biopsy (47 SB only, 79 SB + TB). The age of the patients was 68.7 ± 9.2 years. The median preoperative PSA value was 11.8 ng/mL. Preoperative prostate volume was 60.5 ± 50.0 mL. The numbers of patients with PI-RADS scores of 1 through 5 were 4, 43, 27, 21 and 31, respectively. The overall detection rate of cancer was 61/126 (48.4%), and it was significantly higher in the combination cohort (56/79, 70.9%) compared with the SB only cohort (5/47, 10.6%, p<0.001). When focused on the combination cohort, TB detected a similar overall rate of PCa (53/79, 67.1% vs 52/79, 65.8%; p = 0.87) compared with SB. The clinically significant PCa (csPC) detection rate was 52/79 (65.8%), while for TB and SB the csPC/PC rate was 51/53 (96.2%) and 48/52 (92.3%), respectively(p = 0.44). TB demonstrated a better sampling performance (positive rate for each core) compared with SB (51.0% vs 31.3%, p < 0.001).
Surface-projection-based transperineal cognitive fusion targeted biopsy of the prostate has a good efficacy in detecting PCa.
报告一种新的经会阴前列腺靶向活检(TB)的标准化认知融合技术,并评估其与系统活检(SB)相结合检测癌症的效果。
我们回顾性分析了 2016 年 1 月至 2018 年 12 月期间接受多参数磁共振成像(mpMRI)检查并随后进行经会阴前列腺活检的连续患者。每位患者均进行了徒手 12 核 SB。PI-RADS 3-5 病变进一步采用我们的 TB 技术进行靶向活检。首先,在经直肠超声(TRUS)的横截面上,通过认知在可疑病变的中心点(B')上进行标记。然后,活检枪通过会阴皮肤的固定先锋部位(A)垂直穿刺,并深入到 TRUS 截面以获得 A'。接下来,通过 A 和 B'到 A'的距离,确定会阴皮肤的靶向部位(B),即 B'的表面投影。最后,通过 B 进行穿刺以到达 B'。分析 SB 和 TB 的病理发现。
共有 126 名患者接受了经会阴前列腺活检(47 例仅 SB,79 例 SB+TB)。患者年龄为 68.7±9.2 岁。术前 PSA 中位值为 11.8ng/mL。前列腺体积为 60.5±50.0mL。PI-RADS 评分 1 至 5 的患者人数分别为 4、43、27、21 和 31。癌症的总体检出率为 61/126(48.4%),在联合组(56/79,70.9%)明显高于仅 SB 组(5/47,10.6%,p<0.001)。当重点关注联合组时,TB 检测到 PCa 的总体检出率相似(53/79,67.1%与 52/79,65.8%;p=0.87)与 SB 相比。临床显著前列腺癌(csPC)检出率为 52/79(65.8%),而 TB 和 SB 的 csPC/PC 率分别为 51/53(96.2%)和 48/52(92.3%)(p=0.44)。TB 显示出比 SB 更好的采样效果(每核的阳性率)(51.0%比 31.3%,p<0.001)。
基于表面投影的经会阴认知融合靶向前列腺活检在检测 PCa 方面具有良好的效果。